Prognostic Value of PALBI in Patients With Hepatocellular Carcinoma and Concurrent Chronic Kidney Disease: A Nomogram Development

Documenti analoghi

• Mitochondrial Oxidative Stress in Circulating Leukocytes as a Prognostic Marker in Hepatocellular Carcinoma
  di: Víctor Merino, et al.
  Pubblicazione: (2025)
• The Risk of Developing Hepatocellular Carcinoma Persists in Chronic Hepatitis B Patients Even After the Long‐Term Administration of Nucleos(t)ide Analogs
  di: Kazuhiro Murai, et al.
  Pubblicazione: (2025)
• The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy
  di: Van Khanh Nguyen, et al.
  Pubblicazione: (2026)
• Rechallenge of Atezolizumab Plus Bevacizumab Therapy in Patients With Unresectable Hepatocellular Carcinoma
  di: Yuichiro Suzuki, et al.
  Pubblicazione: (2025)
• Individualized Prognostication Based on Deep‐Learning Models Using Computed Tomography as an Imaging Biomarker After Hepatocellular Carcinoma Resection
  di: Hiroji Shinkawa, et al.
  Pubblicazione: (2025)